Pledging
These are the original issues in this subcategory
  • BREAST CANCER
  • COLORECTAL CANCER
  • LUNG CANCER
Winning Issue » LUNG CANCER


Lung cancer is a disease characterized by uncontrolled cell growth in the tissues of the lung. If left untreated, this growth can spread to other parts of the body. Smoking tobacco is the most common cause of this disease, responsible for more than 80% of all lung cancer cases. Lung cancer accounts for 14% of all new cancers and is the second-most common cancer in men and women, behind prostate and breast cancers. Lung cancer is, by far, the leading cause of cancer death in America, outpacing breast, colon and prostate cancers combined. Nearly 230,000 new lung cancer cases are diagnosed each year and nearly 160,000 deaths annually result from this disease. About two-thirds of those diagnosed with lung cancer are 65 or older, with the average age at the time of diagnosis being about 70. It has been discovered that lung cancer can lie dormant for more than 20 years before turning deadly, helping explain why this disease is so persistent and difficult to treat. Recent studies show that after an initial disease-causing genetic fault, often due to smoking, tumor cells quietly develop numerous new mutations, making different parts of the same tumor genetically unique. The survival rates of people with lung cancer vary depending on the extent, or stage, of the cancer when it is diagnosed. There are now more than 380,000 American survivors of lung cancer, some of whom have used oral anti-cancer drugs which are now available. Oral cancer medications are convenient, less expensive to administer and effective if taken properly. However, our 2011 sequester cuts have impacted the availability of cancer medications to some patients. It is difficult for many cancer doctors, especially community oncologists who operate in nonhospital settings, to keep up with the costs associated with treating Medicare cancer patients who are typically elderly and on fixed incomes.

Fortunately, there is good news for those suffering from this disease. Cuban researches have recently developed a lung cancer vaccine called CimaVax which could soon be available here. CimaVax treats lung cancer's symptoms and could help prevent the disease from recurring in people who have gone a period of time without symptoms. It is thought that for some people, CimaVax could transform lung cancer from an immediate death sentence into a long term, semi-manageable disease like diabetes.


Pending Legislation:
H.R.1416 - Cancer Patient Protection Act of 2015
H.R.2739 - Cancer Drug Coverage Parity Act of 2015



Polling Options

  • I oppose reforming current lung cancer policy and wish to defeat H.R.1416 - Cancer Patient Protection Act of 2015 and H.R.2739 - Cancer Drug Coverage Parity Act of 2015, and also wish to donate resources to the campaign committee of either Rep. Paul Ryan or Sen. Mitch McConnell
  • I support reducing the high cost of oral anticancer drugs by requiring individual health insurance plans to provide the same access to orally administered cancer drugs as they do to those that are administered intravenously, and wish to pass H.R.2739 - Cancer Drug Coverage Parity Act of 2015, and also wish to donate resources to either the campaign committees of Rep. Fred Upton (MI) and/or Rep. Leonard Lance (NJ), or to an advocate group currently working with this issue
  • I support repealing the sequestration as it pertains to the payment for cancer medications by declaring that the budgetary resources sequestered under that order for payments for drugs and biologicals under section 1847A of the Social Security Act (42 U.S.C. 1395w-4) shall be available for obligation for drugs and biologicals furnished on or after the date of the enactment of this Act in the same amount and manner as if such order had not been issued; directing the Secretary of Health and Human Services (HHS) to make any payments under Medicare part B of title XVIII of the Social Security Act as may be required to reimburse for reductions in payments made under the sequestration order for drugs and biologicals furnished on or after April 1, 2013, and before enactment of this Act, and wish to pass H.R.1416 - Cancer Patient Protection Act of 2015, and also wish to donate resources to either the campaign committees of Rep. Tom Price (GA) and/or Rep. Renee Ellmers (NC), or to an advocate group currently working with this issue


Winning Option

  • I support reducing the high cost of oral anticancer drugs by requiring individual health insurance plans to provide the same access to orally administered cancer drugs as they do to those that are administered intravenously, and wish to pass H.R.2739 - Cancer Drug Coverage Parity Act of 2015, and also wish to donate resources to either the campaign committees of Rep. Fred Upton (MI) and/or Rep. Leonard Lance (NJ), or to an advocate group currently working with this issue
You May Pledge Your Support For This Issue With A Monetary
Donation And By Writing A Letter To Your Representatives
Please login to pledge


Pledge Period - Opening Date
February 13, 2020
Pledge Period - Closing Date
February 26, 2020
Trustee Election - Begins
February 20, 2020


Suggest a Trustee for this Presentation Cycle


Suggest a worthy trustee for consideration before Day 16 of this presentation cycle. (Maximum 60 Characters)
Trustee Name